Corvia Medical raises $55m to complete confirmatory heart shunt trial
The US-based company's trial began in 2022 and is currently underway at more than 65 institutions across three continents with 750 patients enrolled, according to the trial's listing on Clinicaltrials.gov.
Increasing Corvia's current funding to around $150m, the latest set of funds originated from the company's existing investment syndicate of Third Rock Ventures, General Catalyst Partners, AccelMed, Lumira Ventures, along with two strategic investors.
Corvia anticipates the double-blind, randomised, sham-controlled confirmatory RESPONDER-HF (NCT05425459) trial of the Corvia atrial shunt system, which is being evaluated to treat heart failure with preserved and mildly reduced ejection fraction (HFpEF/HFmrEF), to generate the final clinical data required to support a regulatory filing with the US Food and Drug Administration (FDA).
The atrial shunt works by creating a small passage between the heart's left and right atria, enabling blood to flow from the high-pressure left side to the lower-pressure right side.
Trial patients randomised to the treatment arm will undergo a fluoroscopically and intra-cardiac echocardiography (ICE), or transoesophageal echocardiography (TEE) guided trans-septal puncture and with the Corvia atrial shunt implant procedure. In addition, patients randomised to the control arm will undergo ICE from the femoral vein or TEE for examination of the atrial septum and left atrium.
Upon completion, patients will be evaluated at pre-specified time intervals and followed for five years.
Corvia CEO George Fazio said: "We are profoundly grateful for the unwavering support of our longstanding investors as we advance toward FDA submission of the Corvia atrial shunt.
"Their commitment furthers our mission to bring this transformative heart failure treatment to millions of patients worldwide."
The funding will provide Corvia with the resources needed to navigate the approval process for the Corvia shunt system and introduce the therapy to the market, added Corvia board chair Paul LaViolette.
Research indicates that around 65 million people worldwide have heart failure, with a majority affected by HFpEF.
In October 2023, Corvia announced positive safety and efficacy results from its REDUCE LAP-HF II (NCT03088033) randomised Phase III trial of its atrial shunt. In comparison to the sham control, patients showed a 50% reduction in the rate of heart failure events and a sustained improvement in quality of life as measured on the Kansas City Cardiomyopathy Questionnaire (KCCQ).
"Corvia Medical raises $55m to complete confirmatory heart shunt trial" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Here's one of the best shares to consider buying as Trump's trade war escalates!
Gold shares like Serabi Gold (LSE:SRB) have been among the most popular stocks to buy as President Trump's trade policy shakes market confidence. Bullion's all-time highs above $3,500 per ounce in April was struck against the backcloth of rising trade tensions. It's a trend I expect to continue. Uncertainty over US trade policy — and the impact of thumping tariffs on economic growth — are natural drivers of safe-haven assets. Gold's receiving extra support, too, from concerns that escalating tariffs will bolster inflation and reduce central banks' appetite to cut interest rates. Gold remains heavily supported by a broadly weaker dollar, uncertainty around tariff announcements and fears about a global recession. Given this situation, Serabi's share price has rocketed 152% over the past year. It's also been propelled higher by the falling US dollar and rising geopolitical tensions. But the Brazilian miner still looks cheap, leading to speculation of further price gains. Its forward price-to-earnings (P/E) ratio is just 3.5 times for 2025. It drops to 3.3 times for next year. Going for gold (stocks) Buying gold shares exposes investors to the risks and unpredictability of the mining industry. This makes it a more dangerous option than buying physical metal, or a fund that simply tracks the gold price. Serabi, which operates in Brazil but reports in US dollars, is also vulnerable to currency volatility. However, this strategy also offers exceptional opportunities to create wealth when the yellow metal surges. Serabi's all-in sustaining costs (AISC) are $1,636 per ounce. If gold prices rise further from current levels of $3,300, every extra dollar will flow straight into the bottom line. This 'leverage effect' means the miner's profits can grow much faster than the bullion price itself (though they can also fall faster when gold drops). The leverage factor partly explains why Serabi's 152% share price gain since last August has outpaced the 36% rise in metal prices. However, it's not the only reason for the company's outperformance. Serabi has also: Reported its highest quarterly production for eight years Raised its mineral resource estimate Made good progress towards more than doubling annual output by 2028 The company's earnings are tipped to rise 87% year on year in 2025. A further 5% rise is tipped for next year. A cheap share I'm considering I hold an exchange-traded fund (the L&G Gold Mining ETF) in my portfolio to capitalise on the leverage effect as gold prices rise. And given its excellent value, I'm also considering buying Serabi shares when I next have cash spare to invest. As well as that having that low P/E ratio, the miner's price-to-earnings growth (PEG) ratio of below 0.1 underlines its cheapness in relation to predicted profits. This is well under the widely accepted value water mark of one. And things remain that way for 2026, with Serabi's PEG coming in at 0.6. While it's not without risk, I think Serabi Gold could be one of the best shares to consider buying in the current climate. The post Here's one of the best shares to consider buying as Trump's trade war escalates! appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool Royston Wild has positions in Legal & General Ucits ETF Plc - L&g Gold Mining Ucits ETF. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
an hour ago
- Bloomberg
Myanmar Remains Upbeat on Trade Talks Despite 40% Trump Tariffs
Myanmar 's military government said it remains upbeat on reaching a deal with the US to see a decrease in Trump's new tariffs of 40% on goods from the Southeast Asian country. 'The US continues to negotiate with us on this so it's still in a stage of negotiation,' Zaw Min Tun, chief spokesman of the ruling State Security and Peace Commission, told Bloomberg News on Saturday.
CNN
an hour ago
- CNN
Trump fires a senior official over jobs numbers
Donald Trump Job market EconomyFacebookTweetLink Follow President Donald Trump has fired Dr. Erika McEntarfer, the commissioner of the Bureau of Labor Statistics, whom he accused, without evidence, of manipulating the monthly jobs reports for 'political purposes.' The BLS' monthly labor report Friday showed that the US economy added only 73,000 jobs in July, far below expectations. It also sharply revised down the employment growth that had been previously reported in May and June – by a combined 258,000 jobs. After the revisions, the jobs report showed the weakest pace of hiring for any three-month period since the pandemic recession in 2020. 'In my opinion, today's Jobs Numbers were RIGGED in order to make the Republicans, and ME, look bad,' Trump said in a Truth Social post. Although the May and June jobs numbers were worse than initially believed, revisions are normal in this process. The BLS' initial monthly jobs estimates are often based on incomplete data, so they are revised twice after the initial report — followed by an annual revision every February. Additionally, BLS economists use a formula to smooth out jobs numbers for seasonal variations and that can exacerbate revisions when they fall outside economists' expectations. Trump on Friday incorrectly called the revisions a 'mistake.' 'McEntarfer said there were only 73,000 Jobs added (a shock!) but, more importantly, that a major mistake was made by them, 258,000 Jobs downward, in the prior two months,' Trump said on Truth Social. 'Similar things happened in the first part of the year, always to the negative. The Economy is BOOMING under 'TRUMP.'' Trump said McEntarfer 'faked' the jobs numbers before the election to try to boost former Vice President Kamala Harris' chances in the 2024 presidential election. 'We're doing so well. I believe the numbers were phony, just like they were before the election, and there were other times. So, you know what I did? I fired her, and you know what? I did the right thing,' Trump told reporters Friday on the South Lawn. McEntarfer was confirmed by the Senate 86-8 in January 2024 for a term of four years. CNN has reached out to McEntarfer for comment. Until Trump replaces McEntarfer, Deputy Commissioner William Wiatrowski will serve as Acting Commissioner, the administration said. Trump has previously criticized the BLS for its jobs data and revisions, and he told reporters Friday evening he's 'always had a problem with these numbers.' In 2016, during his first presidential campaign, Trump claimed that the unemployment rate was significantly higher than the BLS let on. In 2024, he accused former President Joe Biden's administration of orchestrating a cover-up, after the BLS reported that it had overcounted jobs by 818,000 over the previous 12 months. 'I was thinking about it this morning, before the numbers that came out. I said, 'Who is the person that does these numbers?' And then they gave me stats about before the election,' Trump said Friday. 'We need people that we can trust,' he added. But Trump and his administration have also praised the BLS data when it has been favorable to them. During Trump's first term, former White House Press Secretary Sean Spicer said in March 2017 that the jobs data was no longer 'phony' after the BLS issued a strong jobs report. And a month ago, current White House Press Secretary Karoline Leavitt posted on social media that the economy had beat expectations for jobs in four straight BLS labor reports. The BLS is nonpartisan, and businesses and government officials rely on the accuracy of its data to make determinations about investment, hiring, spending and all sorts of key decisions. 'It's outrageous for anyone in government to question the integrity of the BLS,' said Jason Furman, a Harvard professor and former Obama economic adviser. 'Accurate statistics are essential to the economy.' Furman doubted that replacing McEntarfer would compromise the BLS, but he said even the possibility or appearance of that notion 'would be bad.' 'Countries that have tried to fake those statistics have often ended up with economic crises as a result,' Furman said. Mark Zandi, chief economist at Moody's Analytics, said the BLS' data is at the 'highest standard,' and 'as accurate as it can be.' 'Anything that undermines that or even the perception of that high standard is deeply worrisome,' Zandi said. 'I've never seen anything even close to this.' At Moody's, Zandi said he has hired a number of former BLS economists whom he called 'fantastic.' 'They do great work,' Zandi said. 'They are critical to a well-functioning economy.' Democratic Virginia Senator Mark Warner accused Trump of working the referees. 'Firing the ump doesn't change the score,' Warner said in a statement. 'Americans deserve to know the truth about the state of the Trump economy.' But Labor Secretary Lori Chavez-DeRemer said in a post on social media that she supports replacing McEntarfer. 'A recent string of major revisions have come to light and raised concerns about decisions being made by the Biden-appointed Labor Commissioner,' Chavez-DeRemer said on X. 'I support the President's decision to replace Biden's Commissioner and ensure the American People can trust the important and influential data coming from BLS.' The BLS jobs survey is widely considered by economists to be robust. It samples more than 100,000 businesses and government agencies each month, representing roughly 629,000 individual worksites. But, as part of larger cost-cutting taking place around practically every part of Trump's government, the BLS is laying off staff — and, as a result, reducing the scope of its work. For example, the BLS posted a notice in June stating it stopped collecting data for its Consumer Price Index in three cities (Lincoln, Nebraska; Buffalo, New York; and Provo, Utah) and increased 'imputations' for certain items (a statistical technique that, when boiled down to very rough terms, essentially means more educated guesses). That worried Federal Reserve Chair Jerome Powell. In testimony before Congress in June, Powell said he believed the BLS data to be accurate, but he was upset about what could become a trend. 'I wouldn't say that I'm concerned about the data today, although there has been a very mild degradation of the scope of the surveys,' Powell said at the time, in response to a question about survey data quality. 'But I would say the direction of travel is something I'm concerned about.' This story has been updated with additional developments and context.
